Find out more about our subscription products and services by visiting our websites: CorporateHealthcareEnergy
Report Store

Search Within Market Intelligence

Keywords:
Search In
Industry:
Pub Month: From  To 
Price Range ($): Min       Max
 
 
 
 
Free Research Alert
Sign up for updates on the latest research
Email: 
 
 
Call us now on +44 1204 543 529
to speak to an advisor
 

F. Hoffmann-La Roche Ltd. (ROG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published: Mar-2014    Report Format:
Company Report
Single User License
Single User License
$250
Site License
Site License
$500
Global License
Global License
$750
 
 
Save time and money with a subscription
 
Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?
 
To find out more, click here or call +44 1204 543 545.
 
 
F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It discovers, develops, manufactures and markets innovative diagnostics and therapeutic products and services. Roche's products and services address the prevention, diagnosis and treatment of diseases, and improve the well-being and quality of life of patients. The company specializes in in-vitro diagnostics and drugs for cancer and transplantation. Roche classified its operations into two reportable business segments, namely, Pharmaceuticals and Diagnostics. Geographically, the company has operations in various countries across North America, Latin America, Europe Asia, Africa, Australia and Oceania. Roche is headquartered in Basel, Switzerland. Roche envisages establishing itself in the market through new product launches, network expansion, internal development, in-licensing of technology and products, acquisitions and strategic alliances. F. Hoffmann-La Roche Ltd. (ROG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons To Buy

  • Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
  • Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
  • Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
  • Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
  • Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
  • Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
  • Note: Some sections may be missing if data is unavailable for the company.
© GlobalData 2014. John Carpenter House, 7 Carmelite Street, London EC4 O85.